Moscow: Developers of the Sputnik V COVID-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.
The offer comes as AstraZeneca has said it likely will run additional trials on the efficacy of its vaccine.
A vial of ‘Sputnik V’, COVID-19 vaccine.Credit:Bloomberg
Russia said its Sputnik V vaccine is 92 per cent effective at protecting people from COVID-19, according to interim trial results, while AstraZeneca said its COVID-19 vaccine was 70 per cent effective in pivotal trials and could be up to 90 per cent effective.
“If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy,” the developers of the Russian vaccine said on their Twitter account.
